Potential Effectiveness of Applying Soluble Fiber Supplementation with Medical Nutrition Therapy Intervention for People Living with Chronic HIV with Dyslipidemia: A Systematic Review
Article Sidebar
Main Article Content
Abstract
The side effects of antiretroviral drug therapy have been linked to an increase in the prevalence of dyslipidemia among people living with HIV (PLHIV) (ART). Abnormal blood lipid profiles are well known for causing complications such as stroke and ischemic heart failure, which can increase mortality. Soluble fiber has been shown to reduce blood cholesterol and low-density lipoprotein (LDL) cholesterol. Furthermore, medical nutrition therapy (MNT) based on the therapeutic lifestyle change diet (TLC diet) effectively improves blood lipid profiles in PLHIV with dyslipidemia. The data could be used to notify dietetics and other healthcare professionals to provide health support for PLHIV with dyslipidemia and to generate future studies using soluble fiber supplementation in MNT based on TLC diet intervention.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
JHSAM publishes all articles in full open access, meaning unlimited use and reuse of articles with appropriate credit to the authors.
All our articles are published under a Creative Commons "CC-BY-NC-ND 4.0". License which permits use, distribution and reproduction in any medium,
provided that the original work is properly cited and is used for noncommercial purposes.
References
UNAIDS. Global AIDS update 2024; the path that ends AIDS. 2024. Available from: https://www.unaids.org/sites/default/files/media_asset/2024-unaids-global-aids-update-summary_en.pdf
Gnananjali AR, Sumana MN. Profile of opportunistic infections in AIDS patients in relation to CD4 count in a tertiary care hospital. BMC Infect Dis. 2014;14(3):75.
Reust CE. Common adverse effects of antiretroviral therapy for HIV disease. Am Fam Physician. 2011;83(12):1443-51.
Gelaw YK, Adugna B, Tsegaye AT, Melaku T, Kefale B. Coping strategies for adverse effects of antiretroviral therapy among adult HIV patients attending University of Gondar Referral Hospital, Gondar, Northwest Ethiopia: a cross-sectional study. AIDS Res Treat. 2018; 2018:1879198.
Kelesidis T, Currier JS. Dyslipidemia and cardiovascular risk in human immunodeficiency virus infection. Endocrinol Metab Clin North Am. 2014;43(3):665–84.
Triant VA. HIV infection and coronary heart disease: an intersection of epidemics. J Infect Dis. 2012;205(3):355–61.
Feeney ER, Mallon PWG. HIV and HAART-associated dyslipidemia. Open Cardiovasc Med J. 2011;5:49–63.
Tilahun A, Chekol E, Teklemaryam AB, Agidew MM, Tilahun Z, Admassu FT, et al. Prevalence and predictors of dyslipidemia among HAART treated and HAART naive HIV positive clients attending Debre Tabor Hospital, Debre Tabor, Ethiopia. Heliyon. 2022;8(11):e11342.
Feinstein MJ. HIV and cardiovascular disease: from insights to interventions. Top Antivir Med. 2021;29(4):407-11.
Morris SF, Wylie-Rosett J. Medical nutrition therapy: a key to diabetes management and prevention. Clin Diabetes. 2010;28(1):12-18.
Mirmiran P, Hosseinpour-Niazi S, Azizi F. Therapeutic lifestyle change diet enriched in legumes reduces oxidative stress in overweight type 2 diabetic patients: a crossover randomized clinical trial. Eur J Clin Nutr. 2018;72(1):174-6.
Figueiredo SM, Penido MGMG, Guimaraes MMM, Machado LJC, Filho SAV, Fausto MA, et al. Effects of dietary intervention on lipids profile of HIV infected patients on antiretroviral treatment (ART). Eur Sci J. 2013;9(12):32-49.
Gupta L, Khandelwal D, Lal PR, Gupta Y, Kalra S, Dutta D. Factors determining the success of therapeutic lifestyle interventions in diabetes - role of partner and family support. Eur Endocrinol. 2019;15(1):18-24.
Scisney-Matlock M, Bosworth HB, Giger JN, Strickland OL, Harrison RV, Coverson D, et al. Strategies for implementing and sustaining therapeutic lifestyle changes as part of hypertension management in African Americans. Postgrad Med J. 2009;121(3):147-59.
Filteau S, PrayGod G, Kasonka L, Woodd S, Rehman AM, Chisenga M, et al. Effects on mortality of a nutritional intervention for malnourished HIV-infected adults referred for antiretroviral therapy: a randomised controlled trial. BMC Med. 2015;13(17):1-13.
Zhou Q, Wu J, Tang J, Wang JJ, Lu CH, Wang PX. Beneficial effect of higher dietary fiber intake on plasma HDL-C and TC/HDL-C ratio among Chinese rural-to-urban migrant workers. Int J Environ Res. 2015;12(5):4726–38.
Wrottesley SV, Micklesfield LK, Hamill MM, Goldberg GR, Prentice A, Pettifor JM, et al. Dietary intake and body composition in HIV-positive and -negative South African women. Public Health Nutr. 2014;17(7):1603-13.
Manuthu EM, Joshi MD, Lule GN, Karari E. Prevalence of dyslipidemia and dysglycaemia in HIV infected patients. East Afr Med J. 2008;85(1):10-7.
Tadewos A, Addis Z, Ambachew H, Banerjee S. Prevalence of dyslipidemia among HIV-infected patients using first-line highly active antiretroviral therapy in Southern Ethiopia: a cross-sectional comparative group study. AIDS Res Ther. 2012;9(1):31.
Assefa A, Abiye AA, Tadesse TA, Woldu M. Prevalence and factors associated with dyslipidemia among people living with HIV/AIDS on follow-up care at a tertiary care hospital in Ethiopia: a cross-sectional study. Drug Healthc Patient Saf. 2023;15:93-102.
Behera V, Randive M, Sundaray S, Murty MS. Antiretroviral therapy-induced lipodystrophy. BMJ Case Rep. 2015;2015:bcr2014207090.
Nsagha DS, Weledji EP, Assob NJ, Njunda LA, Tanue EA, Kibu OD, et al. Highly active antiretroviral therapy and dyslipidemia in people living with HIV/AIDS in Fako Division, South West Region of Cameroon. BMC Cardiovasc Disord. 2015;15:95.
Shen Y, Wang J, Wang Z, Qi T, Song W, Tang Y, et al. Prevalence of dyslipidemia among antiretroviral-naive HIV-infected individuals in China. Medicine (Baltimore). 2015;94(48):e2201.
Mandal A, Mukherjee A, Lakshmy R, Kabra SK, Lodha R. Dyslipidemia in HIV infected children receiving highly active antiretroviral therapy. Indian J Pediatr. 2016;83(3):226-31.
Husain NE, Ahmed MH. Managing dyslipidemia in HIV/AIDS patients: challenges and solutions. HIV AIDS (Auckl). 2014;7:1-10.
Bruckert E, Rosenbaum D. Lowering LDL-cholesterol through diet: potential role in the statin era. Curr Opin Lipidol. 2011;22(1):43-48.
Wang Q, Ding H, Xu J, Geng W, Liu J, Guo X, et al. Lipids profile among ART-naïve HIV infected patients and men who have sex with men in China: a case control study. Lipids Health Dis. 2016;15(1):149.
Bekolo CE, Nguena MB, Ewane L, Bekoule PS, Kollo B. The lipid profile of HIV-infected patients receiving antiretroviral therapy in a rural Cameroonian population. BMC Public Health. 2014;14:236.
Jellinger PS, Smith DA, Mehta AE, Ganda O, Handelsman Y, Rodbard HW, et al. American association of clinical endocrinologists' guidelines for management of dyslipidemia and prevention of atherosclerosis. Endocr Pract. 2012;18(1):1-78.
Lambeau KV, McRorie JW. Fiber supplements and clinically proven health benefits: How to recognize and recommend an effective fiber therapy. J Am Assoc Nurse Pract. 2017;29(4): 216-23.
Chen C, Zeng Y, Xu J, Zheng H, Liu J, Fan R, et al. Therapeutic effects of soluble dietary fiber consumption on type 2 diabetes mellitus. Exp Ther Med. 2016;12 (2): 1232-42.
Abutair AS, Naser IA, Hamed AT. The effect of soluble fiber supplementation on metabolic syndrome profile among newly diagnosed type 2 diabetes patients. Clin Nutr Res. 2018;7(1): 31-9.
Papathanasopoulos A, Camilleri M. Dietary fiber supplements: effects in obesity and metabolic syndrome and relationship to gastrointestinal functions. Gastroenterology. 2010;138(1): 65-72.
Hall J, Hammerich K, Roberts P. New paradigms in the management of diverticular disease. Curr Probl Surg. 2010;47(9): 680-735.
Viuda‐Martos M, López‐Marcos MC, Fernández‐López J, Sendra E, López‐Vargas JH, Pérez‐Álvarez JA. Role of fiber in cardiovascular diseases: a review. Compr Rev Food Sci Food Saf. 2010;9(2): 240-58.
Ghavami A, Ziaei R, Talebi S, Barghchi H, Nattagh-Eshtivani E, Moradi S, et al. Soluble fiber supplementation and serum lipid profile: a systematic review and dose-response meta-analysis of randomized controlled trials. Adv Nutr. 2023;14(3): 465-74.
Nitzke D, Czermainski J, Rosa C, Coghetto C, Fernandes SA, Carteri RB. Increasing dietary fiber intake for type 2 diabetes mellitus management: a systematic review. World J Diabetes. 2024;15(5):1001-10.
Ramos SC, Fonseca FA, Kasmas SH, Moreira FT, Helfenstein T, Borges NC, et al. The role of soluble fiber intake in patients under highly effective lipid-lowering therapy. Nutr J. 2011;10:80.
Barber TM, Kabisch S, Pfeiffer AFH, Weickert MO. The health benefits of dietary fibre. Nutrients. 2020;12(10): 3209.
Quagliani D, Felt-Gunderson P. Closing America's fiber intake gap: communication strategies from a food and fiber summit. Am J Lifestyle Med. 2016;11(1): 80-5.
Hong SA, Piaseu N. Prevalence and determinants of sufficient fruit and vegetable consumption among primary school children in Nakhon Pathom, Thailand. Nutr Res Pract. 2017;11(2): 130-8.
Ozier AD, Henry BW. Position of the American Dietetic Association: nutrition intervention in the treatment of eating disorders. J Am Diet Assoc. 2011;111(8):1236-41.
Rezazadeh L, Ostadrahimi A, Tutunchi H, Naemi Kermanshahi M, Pourmoradian S. Nutrition interventions to address nutritional problems in HIV-positive patients: translating knowledge into practice. J Health Popul Nutr. 2023;42(1):94.
Balvers MG, Brouwer-Brolsma EM, Endenburg S, de Groot LC, Kok FJ, Gunnewiek JK. Recommended intakes of vitamin D to optimise health, associated circulating 25-hydroxyvitamin D concentrations, and dosing regimens to treat deficiency: workshop report and overview of current literature. J Nutr Sci. 2015;4: e23.
Visser ME, Durao S, Sinclair D, Irlam JH, Siegfried N. Micronutrient supplementation in adults with HIV infection. Cochrane Database Syst Rev. 2017;5(5): CD003650.
Thongtang N, Sukmawan R, Llanes EJB, Lee ZV. Dyslipidemia management for primary prevention of cardiovascular events: Best in-clinic practices. Prev Med Rep. 2022;27: 101819.
Ooi EM, Lichtenstein AH, Millar JS, Diffenderfer MR, Lamon-Fava S, Rasmussen H, et al. Effects of therapeutic lifestyle change diets high and low in dietary fish-derived FAs on lipoprotein metabolism in middle-aged and elderly subjects. J Lipid Res. 2012;53(9):1958-67.
Hosseinpour-Niazi S, Mirmiran P, Fallah-Ghohroudi A, Azizi F. Non-soya legume-based therapeutic lifestyle change diet reduces inflammatory status in diabetic patients: a randomised cross-over clinical trial. Br J Nutr. 2015;114(2): 213-9.
Singhato A, Booranasuksakul U, Khongkhon S, Rueangsri N. Effectiveness of the therapeutic lifestyle change diet intervention to improve biochemical markers of cardiovascular diseases in HIV-infected patients with dyslipidemia. Ann Nutr Metab. 2024:1-9.
Sharifi MH, Eftekhari MH, Ostovan MA, Rezaianazadeh A. Effects of a therapeutic lifestyle change diet and supplementation with Q10 plus L-carnitine on quality of life in patients with myocardial infarction: a randomized clinical trial. J Cardiovasc Thorac Res. 2017;9(1): 21-8.